593 related articles for article (PubMed ID: 16116482)
1. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA; Autexier C; Londoño-Vallejo JA; Bacchetti S
Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482
[TBL] [Abstract][Full Text] [Related]
2. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.
Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR
Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359
[TBL] [Abstract][Full Text] [Related]
3. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
4. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
5. Telomere dynamics and telomerase activity in in vitro immortalised human cells.
Bryan TM; Reddel RR
Eur J Cancer; 1997 Apr; 33(5):767-73. PubMed ID: 9282115
[TBL] [Abstract][Full Text] [Related]
6. Immortalized cells with no detectable telomerase activity. A review.
Reddel RR; Bryan TM; Murnane JP
Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
[TBL] [Abstract][Full Text] [Related]
7. Alternative lengthening of telomeres in mammalian cells.
Henson JD; Neumann AA; Yeager TR; Reddel RR
Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785
[TBL] [Abstract][Full Text] [Related]
8. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL; Bower K; Reddel RR
Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
[TBL] [Abstract][Full Text] [Related]
9. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.
Kang MK; Guo W; Park NH
Cell Growth Differ; 1998 Jan; 9(1):85-95. PubMed ID: 9438392
[TBL] [Abstract][Full Text] [Related]
10. Telomere lengthening in telomerase-negative cells: the ends are coming together.
Scheel C; Poremba C
Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
[TBL] [Abstract][Full Text] [Related]
11. Telomere maintenance by recombination in human cells.
Dunham MA; Neumann AA; Fasching CL; Reddel RR
Nat Genet; 2000 Dec; 26(4):447-50. PubMed ID: 11101843
[TBL] [Abstract][Full Text] [Related]
12. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
13. Telomerase and human tumorigenesis.
Stewart SA; Weinberg RA
Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
[TBL] [Abstract][Full Text] [Related]
14. Telomere length dynamics in telomerase-positive immortal human cell populations.
Bryan TM; Englezou A; Dunham MA; Reddel RR
Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
[TBL] [Abstract][Full Text] [Related]
15. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells.
Compton SA; Choi JH; Cesare AJ; Ozgür S; Griffith JD
Cancer Res; 2007 Feb; 67(4):1513-9. PubMed ID: 17308089
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts.
Small MB; Hubbard K; Pardinas JR; Marcus AM; Dhanaraj SN; Sethi KA
J Cell Physiol; 1996 Sep; 168(3):727-36. PubMed ID: 8816928
[TBL] [Abstract][Full Text] [Related]
17. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells.
Varley H; Pickett HA; Foxon JL; Reddel RR; Royle NJ
Nat Genet; 2002 Mar; 30(3):301-5. PubMed ID: 11919561
[TBL] [Abstract][Full Text] [Related]
19. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome.
Jeyapalan JN; Varley H; Foxon JL; Pollock RE; Jeffreys AJ; Henson JD; Reddel RR; Royle NJ
Hum Mol Genet; 2005 Jul; 14(13):1785-94. PubMed ID: 15888482
[TBL] [Abstract][Full Text] [Related]
20. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
